Delhi High Court Denies AbbVie’s Anti-cMet ADC Patent
C.A.(COMM.IPD-PAT) 44/2023- Delhi High court The article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi high Court against the refusal of their Patent application (Application No. 201817047767) for an anti-cMet antibody drug conjugate by Assistant Controller of Patents and Designs. Background of the Case The appellants filed the…